Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients

NCT07839793 is registered in ClinicalTrials.gov with Navamedic AB as lead sponsor.

NCT NCT07839793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07839793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
Lead sponsor
Navamedic AB
Phase
Phase 4
Overall status
Recruiting
Start date
May 25, 2026
Completion date
June 30, 2027
Enrollment
58 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (disorder)